CommercialReimbursementMedium impact
09.00.32al, Reimbursement for Radiopharmaceutical Agents
Independence Blue Cross·Nuclear Medicine, Radiology, Oncology +1 more·Claims & Billing
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Policy 09.00.32al regarding reimbursement for radiopharmaceutical agents has been updated for commercial plans. The policy becomes effective January 1, 2026, but specific changes to reimbursement criteria or billing requirements are not detailed in the provided content.
Action Required
By December 31, 2025: Billing team must review the full policy document at the provided URL to understand specific changes to radiopharmaceutical reimbursement requirements. Update billing procedures and staff training for any new documentation or prior authorization requirements that may affect nuclear medicine procedures.